Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.

Herrero-Cervera A, Vinué Á, Burks DJ, González-Navarro H.

Diabetologia. 2019 Nov;62(11):2143-2157. doi: 10.1007/s00125-019-4962-6. Epub 2019 Aug 6.

PMID:
31388695
2.

Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes.

Martínez-Hervás S, Sánchez-García V, Herrero-Cervera A, Vinué Á, Real JT, Ascaso JF, Burks DJ, González-Navarro H.

J Transl Med. 2019 Jul 12;17(1):222. doi: 10.1186/s12967-019-1977-1.

3.

Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus.

VinuÉ Á, MartÍnez-HervÁs S, Herrero-Cervera A, SÁnchez-GarcÍa V, AndrÉs-Blasco I, Piqueras L, Sanz MJ, Real JT, Ascaso JF, Burks DJ, GonzÁlez-Navarro H.

Transl Res. 2019 Jan;203:31-48. doi: 10.1016/j.trsl.2018.08.003. Epub 2018 Aug 15.

PMID:
30176239
4.

Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models.

Vinué Á, Herrero-Cervera A, González-Navarro H.

Nutrients. 2018 Jul 21;10(7). pii: E939. doi: 10.3390/nu10070939. Review.

5.

The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.

Vinué Á, Navarro J, Herrero-Cervera A, García-Cubas M, Andrés-Blasco I, Martínez-Hervás S, Real JT, Ascaso JF, González-Navarro H.

Diabetologia. 2017 Sep;60(9):1801-1812. doi: 10.1007/s00125-017-4330-3. Epub 2017 Jun 12.

PMID:
28608285
6.

Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxin β-Receptor pathway.

Andrés-Blasco I, Vinué Á, Herrero-Cervera A, Martínez-Hervás S, Nuñez L, Piqueras L, Ascaso JF, Sanz MJ, Burks DJ, González-Navarro H.

Thromb Haemost. 2016 Aug 1;116(2):379-93. doi: 10.1160/TH15-10-0773. Epub 2016 May 12.

PMID:
27172975
7.

Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.

Andrés-Blasco I, Herrero-Cervera A, Vinué Á, Martínez-Hervás S, Piqueras L, Sanz MJ, Burks DJ, González-Navarro H.

J Endocrinol. 2015 Dec;227(3):179-91. doi: 10.1530/JOE-15-0219. Epub 2015 Sep 30.

PMID:
26423094
8.

Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling.

Vinué Á, Andrés-Blasco I, Herrero-Cervera A, Piqueras L, Andrés V, Burks DJ, Sanz MJ, González-Navarro H.

Biochim Biophys Acta. 2015 Sep;1852(9):1729-42. doi: 10.1016/j.bbadis.2015.05.013. Epub 2015 May 31.

Supplemental Content

Loading ...
Support Center